New pill cuts “bad” cholesterol by 60% in major trial

A new experimental pill called enlicitide dramatically lowered levels of low-density lipoprotein (LDL) cholesterol, often referred to as “bad” cholesterol, by as much as 60%, according to a phase three clinical trial published in The New England Journal of Medicine. If the drug receives approval…

Click here to view the original article.